Actively Recruiting
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Led by Vanderbilt University Medical Center · Updated on 2025-06-24
250
Participants Needed
1
Research Sites
179 weeks
Total Duration
On this page
Sponsors
V
Vanderbilt University Medical Center
Lead Sponsor
U
University of Louisville
Collaborating Sponsor
AI-Summary
What this Trial Is About
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.
CONDITIONS
Official Title
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV infected
You will not qualify if you...
- Not fluent in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
Research Team
G
Grace Wallace, BS
CONTACT
E
Emily Smith, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here